Karyopharm Therapeutics Inc

Research Karyopharm Therapeutics Inc (KPTI) on Bullrun: market cap USD 228.56M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerKPTI
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 228.56M
• Financial periodFY2025
• RevenueUSD 146.07M
• Revenue growth0.6%
• Net income-USD 196.04M
• Free cash flow-USD 75.37M

Valuation Snapshot

latest market cap is USD 228.56M.

About Karyopharm Therapeutics Inc

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases in the United States. The company discovers, develops, and commercializes novel and small molecule Selective Inhibitor of Nuclear Export (SINE) compounds that inhibit the nuclear export protein exportin 1 (XPO1).

Frequently asked questions

What is Karyopharm Therapeutics Inc's market cap?

Karyopharm Therapeutics Inc's market capitalization is USD 228.56M.

What does Karyopharm Therapeutics Inc do?

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases in the United States.